ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer.
Moreno T, Monterde B, González-Silva L, Betancor-Fernández I, Revilla C, Agraz-Doblas A, Freire J, Isidro P, Quevedo L, Blanco R, Montes-Moreno S, Cereceda L, Astudillo A, Casar B, Crespo P, Morales Torres C, Scaffidi P, Gómez-Román J, Salido E, Varela I.
Moreno T, et al. Among authors: scaffidi p.
Oncogene. 2021 Apr;40(16):2923-2935. doi: 10.1038/s41388-021-01748-y. Epub 2021 Mar 19.
Oncogene. 2021.
PMID: 33742126
Free PMC article.